Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Vectura and Sandoz revise VR-315 agreement for U.S.

March 18, 2010

ALS Therapy Development Institute and Aestus to test potential ALS treatments

March 18, 2010

Tekmira and Pfizer collaborate on stable nucleic acid-lipid particle technology

March 17, 2010

Lilly to acquire worldwide license to Acrux's testosterone solution Axiron

March 17, 2010

Medicago and MOU partner to commercially develop influenza vaccines in Japan

March 17, 2010

LLS and Forma to develop new therapies for diffuse large B-cell lymphoma

March 17, 2010

Sigma-Aldrich to sell Pfizer's small-molecule compounds to researchers

March 16, 2010

Orexigen and Patheon enter into exclusive manufacturing agreement for Contrave

March 16, 2010

Eisai and Johns Hopkins to collaborate on development GCPII inhibitors

March 16, 2010

Ipsen grants Rhythm worldwide license for two programs in metabolic disorders

March 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...